Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein

Blood

Volumn 91, Issue 11, 1998, Pages 4127-4135

  Gran, Christine ^b   Bøyum, Arne ^b   Johansen, Rune F ^b   Løvhaug, Dagfinn ^b   Seeberg, Erling C ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; COLONY FORMING UNIT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEGATIVE FEEDBACK; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PURIFICATION;

EID: 0032100445     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4127.411k42_4127_4135     Document Type: Article

References (52)

1. Dorshkind K: Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111, 1990
2. Metcalf D: Hematopoietic regulators: Redundancy or subtlety? Blood 82:3515, 1993
3. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
4. Yoder MC, Williams DA: Matrix molecule interactions with hematopoietic stem cells. Exp Hematol 23:961, 1995
5. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253, 1994
6. Broxmeyer, HE: Suppressor cytokines and regulation of myelopoiesis. Am J Pediatr Hematol Oncol 14:22, 1992
7. Kreja L, Hågå P, Muller-Bérat N, Laerum OD, Sletvold O, Paukovits W: Effects of a hemoregulatory peptide on erythroid and myelopoietic colony formation in vitro. Scand J Haematol 37:79, 1986
8. Foa P, Chillemi F, Lombardi L, Lonati S, Maiolo AT, Polli EE: Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats. Eur J Haematol 39:399, 1987
9. Guigon M, Bonnet D, Lemoine F, Kobari L, Parmentier C, Mary JY, Najman A: Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol 18:1112, 1990
10. + subpopulations in response to growth factors. Blood 82:3307, 1993
11. Bøyum A, Løvhaug D, Boecker WR: Regulation of bone marrow cell growth in diffusion chambers: The effect of adding normal and leukemic (CML) polymorphonuclear granulocytes. Blood 48:373, 1976
12. Bøyum A, Løvhaug D, Kolstø AB, Helgestad J, Melby T: Colony inhibiting factor in mature granulocytes from normal individuals and patients with chronic myeloid leukemia. Eur J Haematol 38:318, 1987
13. Bøyum A, Løvhaug D, Seeberg E, Nordlie EM: Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation. Exp Hematol 22:208, 1994
14. Bøyum A, Helgestad J, Løvhaug D: Thymidine-dependent effect of granulocyte-derived inhibitor on granulocyte-macrophage progenitor cells (GM-CFC). Eur J Haematol 40:119, 1988
15. Camiener GW, Smith CG: Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. Biochem Pharmacol 14:1405, 1965
16. Kühn K, Bertling WM, Emmrich F: Cloning of a functional cDNA for human cytidine deaminase (cdd) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun 190:1, 1993
17. 3. Leuk Res 12:405, 1988
18. Chabner BA, Johns DG, Coleman CN, Drake JC, Evans WH: Purification and properties of cytidine deaminase from normal and leukemic granulocytes. J Clin Invest 53:922, 1974
19. Yu C-L, Tsai C-Y, Sun K-H, Chen Y-S, Lin W-M, Liao T-S, Chen K-H, Wang S-R: Increased spontaneous release of cytidine deaminase by polymorphonuclear neutrophils of patients with active systemiclupus erythematosus. Br J Rheumatol 31:675, 1992
20. Månsson B, Geborek P, Saxne T, Bjørnsson S: Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: Relation to lactoferrin, acidosis, and cartilage proteoglycan release. Ann Rheum Dis 49:594, 1990
21. Song B-H, Neuhard J: Chromosomal location, cloning and nucleotide sequence of the Bacillus subtilis cdd gene encoding cytidine/deoxycytidine deaminase. Mol Gen Genet 216:462, 1989
22. + gene products. Proc Natl Acad Sci USA 75:2569, 1978
23. Schägger H, von Jagow G: Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368, 1987
24. Bøyum A, Løvhaug D, Tresland L, Nordlie EM: Separation of leucocytes: Improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 34:697, 1991
25. Betts L, Xiang S, Short SA, Wolfenden R, Carter CW Jr: Cytidine deaminase. The 2.3 Å crystal structure of an enzyme: Transition-state analog complex. J Mol Biol 235:635, 1994
26. Carlow DC, Smith AA, Yang CC, Short SA, Wolfenden R: Major contribution of a carboxymethyl group to transition-state stabilization by cytidine deaminase: Mutation and rescue. Biochemistry 34:4220, 1995
27. Weiner KXB, Weiner RS, Maley F, Maley GF: Primary structure of human deoxycytidylate deaminase and overexpression of its functional protein in Escherichia coli. J Biol Chem 268:12983, 1993
28. Laliberté J, Momparler RL: Human cytidine deaminase: Purification of enzyme, cloning, and expression of its complementary DNA. Cancer Res 54:5401, 1994
29. Cacciamani T, Vita A, Cristalli G, Vincenzetti S, Natalini P, Ruggieri S, Amici A, Magni G: Purification of human cytidine deaminase: Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs. Arch Biochem Biophys 290:285, 1991
30. Vincenzetti S, Cambi A, Neuhard J, Garattini E, Vita A: Recombinant human cytidine deaminase: Expression, purification, and characterization. Prot Expr Purif 8:247, 1996
31. + progenitors. Exp Hematol 23:551, 1995
32. Grindey GB, Wang MC, Kinahan JJ: Thymidine induced perturbations in ribonucleoside and deoxyribonucleoside triphosphate pools in human leukemic CCRF-CEM cells. Mol Pharmacol 16:601, 1979
33. Moore EC, Hurlbert RB: Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. J Biol Chem 241:4802, 1966
34. Murphree S, Moore EC, Beall PT: Regulation by nucleotides of the activity of partially purified ribonucleotide reductase from rat embryos. Cancer Res 28:860, 1968
35. Reichard P: From deoxynucleotides to DNA synthesis. Federation Proc 37:9, 1978
36. Thelander L, Reichard P: Reduction of ribonucleotides. Annu Rev Biochem 48:133, 1979
37. Bjursell G, Reichard P: Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem 248:3904, 1973
38. Ensminger WD, Frei E III: The prevention of methotrexate toxicity by thymidine infusions in humans. Cancer Res 37:1857, 1977
39. Skutelsky E, Danon D: On the expulsion of erythroid nucleus and its phagocytosis. Anat Res 173:123, 1972
40. Stadecker MJ, Calderon J, Karnovsky ML, Unanue ER: Synthesis and release of thymidine by macrophages. J Immunol 119:1738, 1977
41. Dong R-P, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C: Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156:1349, 1996
42. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466, 1993
43. Martin M, Huguet J, Centelles JJ, Franco R: Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. J Immunol 155:4630, 1995
44. Marone G, plaut M, Lichtenstein LM: Characterization of a specific adenosine receptor on human lymphocytes. J Immunol 11: 2153, 1978
45. Schwartz AL, Stern RC, Polmar SH: Demonstration of an adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency. Clin Immunol Immunopathol 9:499, 1978
46. Lindley ER, Pisoni RL: Demonstration of adenosine deaminase activity in human fibroblast lysosomes. Biochem J 290:457, 1993
47. De Korte D, Haverkort, WA, van Gennip AH, Roos D: Nucleotide profiles of normal human blood cells determined by high-performance liquid chromatography. Anal Biochem 147:197, 1985
48. Nakamura H, Natsumeda Y, Nagai M, Takahara J, Irino S, Weber G: Reciprocal alterations of GMP reductase and IMP dehydrogenase activities during differentiation in HL-60 leukemia cells. Leuk Res 16:561, 1992
49. +-dependent nucleoside transport system. In Vivo 8:795, 1994
50. +-dependent uridine transport in dimethyl-sulphoxide-induced HL-60 leukaemia cells. Biochem J 280:515, 1991
51. +-dependent uridine transporter activity in HL-60 granulocytes by N-formylmethionyl-leucyl-phenylalanine. Biochem J 294:693, 1993
52. Scott J: A place in the world for RNA editing. Cell 81:833, 1995